Peer Exchange Tap into peer-to-peer dialogues covering different therapeutic areas in easy to digest videos, featuring managed care thought leaders.
All Peer Exchange Understanding the Comorbidities: Psoriasis and Metabolic Syndrome Managing Challenges of Insomnia in Elderly Patients The Challenges and Treatment of Sickle Cell Disease Identifying Secondary Progressive Multiple Sclerosis A Review of the Treatment for Multiple Myeloma Rare Neurological Diseases: Spinal Muscular Atrophy and Huntington's Disease An Introduction of a New Class for the Treatment of Bone Health An Overview of the Value-Based Marketplace The Progression of Type 2 Diabetes and the Treatment Options to Manage It Immunotherapy in the Oncology Care Model Preventive Treatments for Migraines The Use of Biologics for the Treatment of Asthma Improved Outcomes in the Management of Hepatic Encephalopathy Expert Perspectives on Schizophrenia Treatment Approaches and Relapse Prevention Advances and Best Practices in the Utilization of Novel Agents in Metastatic Breast Cancer Oncology Stakeholders Summit, Summer 2018 Emerging Treatment for Migraine Advances in the Treatment of Hyperhidrosis Special Considerations in HIV Management Finding Value in Today's New Insulin Technology in Diabetes Care: From Prevention to Disease Management
Age-Related Macular Degeneration Treatments: Determining Appropriate Use Diabetes Therapy and Cardiovascular Outcomes: An Update Oncology Stakeholders Summit, Spring 2017 Reducing CVD Risk Through Optimal Lipid Management Oncology Stakeholders Summit, Fall 2016 Management Optimization in Atopic Dermatitis Oral Oncolytics: Exploring Challenges in Cost, Adherence, and Management Reducing Cardiovascular Mortality in Patients With Type 2 Diabetes Mellitus Oncology Stakeholders Summit, Spring 2016 Diabetes-Related Complications: A Focus on Diabetic Macular Edema Oncology Stakeholders Summit, Fall 2015 Healthcare Reform Stakeholders Summit, Fall 2015 Healthcare Reform Stakeholders Summit, Spring 2015 Oncology Stakeholders Summit, Spring 2015 Oncology Stakeholders Summit 2014 Diabetes and Obesity Management Prostate Cancer Rare Disease Neurological Disorders Immunotherapy Diabetes and Cardiometabolic Health
November 19, 2019 –
A review of the IL-23 inhibitors and their long-term and safety data.
November 19, 2019 –
The panel discusses the potential for decreased efficacy of treatment based on comorbidities. They also discuss the use of PASI score vs BSA to determine severity of disease and the need to identify responders and nonresponders to specific agents.
November 12, 2019 –
Experts delve into their treatment plan based on additional comorbidities patients may have.
November 12, 2019 –
A discussion on the dual orexin receptor antagonist suvorexant, and its role in treating elderly patients with insomnia.
November 12, 2019 –
Experts in the field of insomnia consider the efficacy of “Z-drugs” in treating insomnia, and the adverse effects of prescription medications.
November 12, 2019 –
A discussion on the patient preference for specific medications based on administration and dosing schedule, and the payer approval process.
November 06, 2019 –
Concluding their reflection on gene therapy, the panelists provide closing considerations for the future management of sickle cell disease.
November 05, 2019 –
The panel provides an understanding of the different biologics and the various mechanisms of action.
November 05, 2019 –
Key opinion leaders enumerate the prescription medication options available for elderly patients with insomnia.
November 05, 2019 –
When to transition from over-the-counter treatment options to prescription medication.
